2,230 Shares of The Allstate Corporation $ALL Purchased by Norris Perne & French LLP MI

Norris Perne & French LLP MI acquired a new position in shares of The Allstate Corporation (NYSE:ALL – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 2,230 shares of the insurance provider’s stock, valued at approximately $495,000.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. BlackRock Inc. acquired a new position in shares of Allstate during the second quarter worth approximately $5,439,448,000. Bank of America Corp DE grew its stake in shares of Allstate by 8.1% during the first quarter. Bank of America Corp DE now owns 7,913,320 shares of the insurance provider’s stock valued at $1,640,748,000 after purchasing an additional 596,321 shares during the last quarter. GQG Partners LLC bought a new stake in shares of Allstate during the second quarter valued at approximately $1,245,710,000. Deutsche Bank AG acquired a new stake in shares of Allstate in the second quarter valued at approximately $1,008,648,000. Finally, Dimensional Fund Advisors LP increased its holdings in shares of Allstate by 5.8% in the first quarter. Dimensional Fund Advisors LP now owns 2,804,615 shares of the insurance provider’s stock valued at $581,515,000 after purchasing an additional 154,259 shares in the last quarter. Institutional investors own 76.47% of the company’s stock.

Allstate Trading Down 2.3%

ALL opened at $253.24 on Friday. The company has a debt-to-equity ratio of 0.24, a current ratio of 0.36 and a quick ratio of 0.36. The company has a market cap of $64.03 billion, a price-to-earnings ratio of 5.06, a price-to-earnings-growth ratio of 0.56 and a beta of 0.13. The firm has a 50 day simple moving average of $245.78 and a 200 day simple moving average of $236.63. The Allstate Corporation has a fifty-two week low of $188.08 and a fifty-two week high of $277.22.

Allstate (NYSE:ALL – Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The insurance provider reported $8.99 earnings per share for the quarter, beating the consensus estimate of $6.06 by $2.93. Allstate had a net margin of 18.97% and a return on equity of 41.64%. The business had revenue of $18.60 billion for the quarter, compared to analyst estimates of $15.46 billion. During the same period in the prior year, the business posted $5.94 earnings per share. Allstate’s revenue was up 11.8% compared to the same quarter last year. On average, sell-side analysts anticipate that The Allstate Corporation will post 36.21 earnings per share for the current year.

Insider Buying and Selling at Allstate

In other news, insider John E. Dugenske sold 32,996 shares of the firm’s stock in a transaction on Friday, August 7th. The stock was sold at an average price of $269.33, for a total value of $8,886,812.68. Following the transaction, the insider directly owned 13,054 shares in the company, valued at $3,515,833.82. This trade represents a 71.65% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, COO Mario Rizzo sold 56,225 shares of the firm’s stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $264.48, for a total value of $14,870,388.00. Following the completion of the transaction, the chief operating officer owned 82,227 shares in the company, valued at $21,747,396.96. This represents a 40.61% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 1.55% of the company’s stock.

Analyst Ratings Changes

Several research analysts have issued reports on the company. Weiss Ratings raised Allstate from a “buy (a-)” rating to a “buy (a)” rating in a report on Wednesday, October 14th. UBS Group increased their price objective on Allstate from $261.00 to $275.00 and gave the company a “neutral” rating in a research report on Monday, August 10th. Mizuho lowered their target price on Allstate from $300.00 to $295.00 and set an “outperform” rating for the company in a research note on Wednesday, October 7th. Morgan Stanley lowered their target price on Allstate from $265.00 to $240.00 and set an “equal weight” rating for the company in a research note on Tuesday, October 6th. Finally, JPMorgan Chase & Co. upped their price target on Allstate from $282.00 to $292.00 and gave the company an “overweight” rating in a research note on Tuesday, August 11th. Two investment analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating, nine have assigned a Hold rating and three have given a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $270.19.

View Our Latest Report on ALL

Key Headlines Impacting Allstate

Here are the key news stories impacting Allstate this week:

  • Positive Sentiment: Allstate prevailed in a Texas coverage dispute involving a vacant property. The ruling supports the insurer’s ability to enforce policy vacancy provisions, potentially limiting claims costs and reinforcing underwriting discipline. Vacant clause can void cover: US court backs Allstate in Texas case
  • Positive Sentiment: Allstate retained $9,000 in a subrogation-related dispute after a court placed the premature filing cost on the opposing liability carrier. The financial impact is small, but the decision may support Allstate’s claims-handling position. Allstate keeps $9,000 as premature subrogation cost falls on liability carrier
  • Positive Sentiment: Bank of America raised its price target on Allstate to $340 from $336, signaling continued confidence in the insurer’s earnings outlook and valuation. BofA raises target from $336 to $340
  • Positive Sentiment: A valuation-focused analysis said Allstate still appears inexpensive despite a 131% advance, potentially attracting investors who expect further benefits from strong insurance pricing and improved profitability. Allstate stock still looks cheap after its 131% run
  • Neutral Sentiment: Allstate shares gained 3.76% in the referenced session, although KBW maintained its Sell rating, highlighting a disconnect between short-term trading momentum and analyst conviction. KBW keeps Sell rating
  • Neutral Sentiment: UBS reiterated its Hold rating, offering no new catalyst but indicating the firm sees limited justification for changing its current view. UBS keeps Hold rating
  • Negative Sentiment: Analysts expect Allstate’s third-quarter earnings per share to decline by double digits year over year, creating concern ahead of the company’s November earnings release. What to expect from Allstate’s next quarterly earnings report
  • Negative Sentiment: KBW’s continued Sell rating remains a notable overhang, suggesting the firm believes Allstate’s strong rally has outpaced its fundamental value. KBW keeps Sell rating
  • Negative Sentiment: The price target for Allstate’s preferred stock was reduced 12.29% to $19.21, signaling weaker expectations for that security, although it does not directly change the valuation of the common shares. Allstate preferred stock price target decreased

Allstate Company Profile

(Free Report)

Allstate Corp. (NYSE: ALL) is an insurance company that provides protection products and related services primarily in the United States. Its offerings include automobile, homeowners, renters, condominium, motorcycle and other personal property and casualty insurance, distributed through agents, brokers, direct channels and digital platforms.

The company also provides roadside assistance, identity-protection services and protection plans for consumer products. Through its acquisition of National General, Allstate expanded its presence in independent-agent distribution and specialty personal insurance.

Recommended Stories

Institutional Ownership by Quarter for Allstate (NYSE:ALL)

Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.